Benzydamine reduces prostaglandin production in human gingival fibroblasts challenged with interleukin-1β or tumor necrosis factor α

Acta Odontologica Scandinavica

Volumn 57, Issue 1, 1999, Pages 40-45

  Modéer, Thomas ^a   Yucel Lindberg, Tülay ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Interleukin 1 ; Prostaglandin E2; Prostaglandin I2; Tumor necrosis factor

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; BENZYDAMINE; PHOSPHOLIPASE A2; PHOSPHOLIPID; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRITIUM;

ANALGESIC ACTIVITY; ANESTHESIA; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; PROSTAGLANDIN SYNTHESIS;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZYDAMINE; CELLS, CULTURED; CHILD; DINOPROSTONE; FIBROBLASTS; GINGIVA; HUMANS; INTERLEUKIN-1; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; PROSTAGLANDINS F; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344076054     PISSN: 00016357     EISSN: None     Source Type: Journal    
DOI: 10.1080/000163599429093     Document Type: Article

References (27)

1. Silvestrini B, Garau A, Pozzatti C, Cioli V. Pharmacological research on benzydamine a new analgesic anti-inflammatory drug. Arzneimittelforschung 1966;16:59-63.
2. Lisciani R, Barcellona PS, Silvestrini B. Researches on the topical activity of benzydamine. Eur J Pharmacol 1968;3:157-62.
3. Hunter KM. A clinical evaluation of benzydamine hydrochloride. Aust Dent J 1978;23:164-6.
4. Cioli V, Corradino C, Scorza Barcellona P. Review of pharmacological data on benzydamine. Int J Tissue React 1985; 7:205-13.
5. White BA, Lockhart PB, Connolly SF, Sonis ST. The use of infrared thermography in the evaluation of oral lesions. Int J Tissue React 1987;9:105-14.
6. Turnbull RS. Benzydamine hydrochloride (Tantum) in the management of oral inflammatory conditions. J Can Dent Assoc 1995;61:127-34.
7. Landry RG, Turnbull RS, Howley T. Effectiveness of benzydamine HCl in the treatment of periodontal post-surgical patients. Res Clin Forum 1988;10:105-17.
8. Segre G, Hammarström S. Aspects of the mechanisms of action of benzydamine. Int J Tissue React 1985;7:187-93.
9. Sironi M, Pozzi P, Polentarutti N, Benigni F, Coletta I, Guglielmotti A, et al. Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine. Cytokine 1996;8:710-16.
10. Sironi M, Milanese C, Vecchi A, Polenzani L, Guglielmotti A, Coletta I, et al. Benzydamine inhibits the release of tumor necrosis factor-and monocyte chemotactic protein-1 by candida albicans-stimulated human peripheral blood cells. Int J Clin Lab Res 1997;27:118-22.
11. Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping activities. Lab Invest 1987;56:234-48.
12. Dinarello CA. Biology of interleukin-1. FASEB J 1988;2:108-15.
13. Henderson B, Blake S. Therapeutic potential of cytokine manipulation. TiPS 1992;13:145-52.
14. Richards D, Rutherford RB. The effects of interleukin-1 on collagenolytic activity and prostaglandin-E secretion by human periodontal-ligament and gingival fibroblasts. Arch Oral Biol 1988;33:237-43.
15. Modéer T, Brunius G, Iinuma M, Lerner UH. Phenytoin potentiates interleukin-1-induced prostaglandin biosynthesis in human gingival fibroblasts. Br J Pharmacol 1992;106:574-8.
16. Diaz A, Reginato AM, Jimenez SA. Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor β1, interleukin 1β, and tumor necrosis factor α. J Biol Chem 1992;267:10816-22.
17. Modéer T, Dahllöf G, Otteskog P. The effect of the phenytoin metabolite p-HPPH on proliferation of gingival fibroblasts in vitro. Acta Odontol Scand 1982;40:353-7.
18. Epstein JB, Stevenson-Moore P, Jackson S, Mohamed JH, Spinelli JJ. Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse. Int J Radiat Oncol Biol Phys 1989;16:1571-5.
19. Yankell SL, Welsh CA, Cohen DW. Evaluation of benzydamine HCl in patients with apthous ulcers. Comp Cont Educ 1981; 2:14-6.
20. Goppelt-Strübe M, Röbbecke K, Golombek M, Resch K. Effects of benzydamine on the prostaglandin synthesis of macrophages. Arzneimittelforschung 1987;37:621-3.
21. 2 production in human gingival fibroblasts challenged with tumor necrosis factor alpha in vitro. J Oral Pathol Med 1997;26:11-6.
22. Yucel-Lindberg T, Ahola H, Nilsson S, Carlstedt-Duke J, Modéer T. Interleukin-1β induces expression of cyclooxygenase-2 mRNA in human gingival fibroblasts. Inflammation 1995; 19:549-60.
23. Modéer T, Andurén I, Lerner UH. Enhanced prostaglandin biosynthesis in human gingival fibroblasts isolated from patients treated with phenytoin. J Oral Pathol Med 1992;21:251-5.
24. Deby C, Deby-Dupont G, Hans P, Pincemail J, Bourdon-Neuray J. Stimulation of cyclo-oxygenase by lidocaine, a pro-lipoperoxidant. Experientia 1983;39:1364-6.
25. Offenbacher S, Odle BM, Gray RC, Van Dyke TE. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J Periodont Res 1984;19:1-13.
26. 2 and tumor necrosis factor α in experimental gingivitis in humans. J Periodont Res 1993;28:241-7.
27. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-44.